Filing Details

Accession Number:
0001633970-15-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-19 09:39:23
Reporting Period:
2015-02-17
Filing Date:
2015-02-19
Accepted Time:
2015-02-19 09:39:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612314 Nielsen Kurt C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-17 48,040 $10.71 71,716 No 4 M Direct
Common Stock Disposition 2015-02-17 28,040 $27.41 43,676 No 4 F Direct
Common Stock Disposition 2015-02-17 20,000 $27.41 23,676 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2015-02-17 48,040 $0.00 48,040 $10.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,960 2011-02-09 2020-02-09 No 4 M Direct
Footnotes
  1. Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options.
  2. These shares were sold in multiple transactions at prices ranging from $27.33 to $27.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. On February 9, 2010, the reporting person was granted an option to purchase 105,000 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on February 9, 2011.